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BRENYAH, HEINI-MARIA:  The role of Robo4 molecule in leukocyte traffic 
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Leukocyte traffic is an essential part of the immune system as lymphocytes continuously 
migrate to lymph nodes in search of foreign antigens. Lymphocytes can access the lymph 
node either via blood vasculature or afferent lymphatics. A potential molecule in regulat-
ing these pathways is the Roundabout Guidance Receptor 4 (Robo4). Robo4 is expressed 
in blood vessels, the medullary sinus of the lymph nodes and Peyer’s patch (PP) lymphat-
ics. Peyer’s patches are located in the small intestine and merely have efferent lymphatics. 
 
In this study Robo4 knockout (KO) and wild type mouse models were used to investigate 
the effects of Robo4 on leukocyte migration. A monoclonal Robo4 murine antibody was 
generated to explore the Robo4 expression and localization with imaging. Furthermore, 
the function of Robo4 in the leucocyte migration and B cell turnover in Peyer’s patches 
was examined.  
 
The localization of Robo4 expression was limited specifically to the medullary sinus of 
the mouse lymph node and lymphatics of the PPs. Robo4 had a small effect on the migra-
tion of lymphocytes into the lymphoid tissues via blood vessels in vivo, and it controlled 
the adhesion between lymphocytes and the medullary sinus in vitro. Moreover, Robo4 
contributed specifically to naïve B cell turnover in PPs because the percentage of naïve 
B cells was increased in the Robo4 KO mice. Interestingly, concomitant increase in PP 
size or increased apoptosis was not observed as a compensatory mechanism. In conclu-
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ARTICLE
Robo4 contributes to the turnover of Peyer’s patch B cells
Ruth Fair-Mäkelä1, Milas Ugur2, Imtiaz Iftakhar-E-Khuda1, Laura Kähäri1, Anu Kukkonen-Macchi1, Heini-Maria Brenyah1, Kati Elima1,
Masayuki Miyasaka1, Oliver Pabst2 and Sirpa Jalkanen1
All leukocytes can get entrance into the draining lymph nodes via the afferent lymphatics but only lymphoid cells can leave the
nodes. The molecular mechanisms behind this phenomenon have remained unknown. We employed genome wide microarray
analyses of the subcapsular sinus and lymphatic sinus (LS) endothelial cells and found Robo4 to be selectively expressed on LS
lymphatics. Further analyses showed high Robo4 expression in lymphatic vessels of Peyer’s patches, which only have efferent
lymphatic vessels. In functional assays, Robo4-deficient animals showed accumulation of naïve B cells (CD19+/CD62Lhi/CD44lo) in
Peyer’s patches, whereas no difference was seen within other lymphocyte subtypes. Short-term lymphocyte homing via high
endothelial venules to peripheral and mesenteric lymph nodes and Peyer’s patches was also slightly impaired in Robo4 knockout
animals. These results show for the first time, selective expression of Robo4 in the efferent arm of the lymphatics and its role in
controlling the turnover of a subset of B lymphocytes from Peyer’s patches.
Mucosal Immunology (2020) 13:245–256; https://doi.org/10.1038/s41385-019-0230-9
INTRODUCTION
Lymphocytes recirculate continuously between the blood and
lymphatic organs.1 Most lymphocytes enter the lymphoid organs
via the high endothelial venules. Molecular mechanisms and
different phases in lymphocyte–blood vessel endothelial cell
interactions during the lymphocyte extravasation have been
extensively studied during the last 30 years and are currently
well known.2–5 In contrast, cell trafficking via the lymphatics is
much less characterized although it is a central functional part of
our immune system and a route for cancer cells to metastasize.
Certain lymphocytes, dendritic cells, and other leukocytes
together with antigens enter the lymph nodes via afferent
lymphatic vessels, which drain to the subcapsular sinus (SS) of
the lymph nodes. In physiological conditions only lymphoid cells,
however, can exit the nodes via the efferent lymphatic sinuses
(LS).6–8 The exit routes for lymphoid cells go via chains of lymph
nodes.9 For example, cells leaving the popliteal lymph nodes go
next to sacral and further to iliac lymph nodes and cells leaving
the Peyer’s patches (PP) go to the mesenteric lymph nodes
(MLN).10,11 Although discriminative trafficking between the
afferent and efferent arms is a well-known phenomenon, its
molecular basis has remained largely unknown.
We have characterized the afferent and efferent lymphatic
endothelial cells (LEC) of the lymph nodes and found a multitude
of molecular differences between these different arms of the
lymphatic system.12 One of the differently expressed molecules
was magic roundabout, i.e. Robo4, a member of the Roundabout
axon guidance family.12 The microarray data can be found at
www.ncbi.nlm.nih.gov/geo (accession no. GSE68371). Robo4 was
first characterized on blood endothelium,13 although it is also
expressed on hematopoietic stem cells in the bone marrow. It
determines their location in the bone marrow niches and
regulates directional trafficking of the stem cells.14,15 On blood
endothelium Robo4 contributes to endothelial cell integrity, as
well as to permeability and inhibits pathologic angiogenesis by
antagonizing the function of VEGF.16 Robo4 has been reported to
interact with UNC5B and Slit2, although there has been some
debate about the role of Slit2 as a ligand of Robo4.17–19 Slit2 was
found to inhibit lipopolysaccharide-induced secretion of certain
inflammatory mediators and monocyte adhesion to the endothe-
lium in a Robo4-mediated fashion suggesting the importance of
the Slit2–Robo4 pathway in regulating the state of the endothe-
lium at sites of inflammation.20
The role of Robo4 on lymphatics is poorly known. To date, it has
only been studied by using LEC in vitro. Slit2-inhibited VEGF-C-
induced proliferation, migration, and tube formation of LEC
in vitro and the effect was Robo4 dependent.21 In this present
study, we found selective expression of Robo4 in the efferent arm
of the lymphatics and explored its possible role in lymphocyte
turnover in the peripheral and mucosal nodes. The results indicate
a new function for Robo4: it controls turnover of a B cell
subpopulation in PP.
RESULTS
Robo4 is preferentially expressed on the efferent arm of the
lymphatics
Genome wide microarray analyses were performed using RNA from
isolated LECs of murine SS and LS using the laser capture micro-
dissection method and cell sorting with flow cytometry.12 The
purpose was to identify differentially expressed genes between
the afferent and efferent arms of the lymphatic vasculature in the
lymph nodes. In combined analyses, Robo4 had a 13.1-fold higher
expression in LS than in SS (www.ncbi.nlm.nih.gov/geo (accession
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no. GSE68371)). Expression of Robo4 on lymphatics as such was in
agreement with the ImmGen data regarding Robo4 expression in
blood and lymphatic vessel endothelial cells (http://www.immgen.
org/databrowser/, Fig. 1a, b), and therefore, we wanted to analyze
its role in the lymphatics more closely. It turned out that
none of the tested antibodies (commercial and available)
worked in immunohistochemical stainings in mouse, but did so
in immunofluorescence stainings of cell suspensions followed by
FACS analyses. To check whether Robo4 is present on the
efferent lymphatics, we first stained lineage−, CD45−/podopla-
nin+/LYVE1+ cells from peripheral and mesenteric lymph nodes
(PLN and MLN pooled) (Fig. 1c). To analyze Robo4 expression in
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immunohistochemical stainings, we produced a monoclonal anti-
murine Robo4 antibody by taking advantage of Robo4 KO animals
(Fig. S1a–e). To detect Robo4 in the lymph node we administered
the Robo4 antibody subcutaneously (s.c.) into the footpads of
C57BL/6 mice to harness the draining lymphatics to deliver the
antibody to its targets in the draining lymph node. Non-specific
binding of the antibody to macrophage Fc receptors was blocked
using Fc receptor-blocking antibodies and mouse immunoglobu-
lins administered before and with the anti-Robo4 antibody.22
Robo4 expression was detected mainly in the efferent lymphatics in
the medullary region (Figs. 1d and S2a, b). Very faint Robo4
expression was also visible in the LYVE1− LECs of the SS roof,
whereas the LYVE1+ floor seemed to be negative for Robo4
(Fig. 1d). According to the observations by Kähäri et al.22 s.c.
injected antibodies do not reach the luminal side of blood vessels,
which may well explain why we were not able to detect vascular
Robo4 after s.c. injection of the antibody (Fig. 1d). Expression of
Robo4 was particularly high and homogenous in LECs isolated from
PP Fig. 1e, f). This observation is consistent with the lack of afferent
lymphatics in PP. Thus, LECs within PP might mostly resemble
efferent lymphatics and consistently express Robo4. Moreover, we
tested Robo4 expression on lymphatics leading from the gut to the
MLN (Fig. 1e). Expression of Robo4 on LYVE1+ LEC was higher in
the close vicinity to the gut than on lymphatic vessels further away
leading to the MLN, which become afferent vessels for MLN by
definition (Fig. 1g, h).
Heterogeneous expression of Robo4 was seen in LECs of PLN and
MLN. Only a subpopulation was as highly positive as in PP while the
rest of the LEC were practically negative (Fig. 1c). Similarly, we
stained skin lymphatics, which all are afferent lymphatics by
definition. Very little staining was seen in these cells (Fig. 1i).
Robo4 on human efferent lymphatics supports lymphocyte
binding
Next, we tested whether the expression of human Robo4
resembles that of mouse. Also in human lymph nodes collected
from the head and neck region, Robo4 was expressed on a subset
of LS endothelial cells and it was absent from the lymphatic
endothelium in SS (Fig. 2a, b). We used the appendix as an
organized human mucosal lymphoid tissue in the expression
analyses. A subpopulation of Prox-1-positive lymphatics in human
appendix was Robo4 positive (Fig. 2c). To explore a possible role of
human Robo4 on the LS endothelium, we performed ex vivo
frozen section-binding assays. In this assay, lymphocytes bind
specifically to the lymphatic endothelium in the SS and LS (and to
high endothelial venules, HEV, which are easy to discriminate from
the lymphatic endothelium by their plump morphology).12,23 Anti-
Robo4 antibody significantly inhibited lymphocyte binding to the
lymphatic endothelium in the LS but not in the SS (Fig. 2d, Fig.
S3a–d) suggesting that Robo4 on the lymphatic endothelium of LS
directly interacts with lymphocytes.
The major lymphocyte pools and lymphatic architecture is normal
in Robo4 knockout mice
Next, we took advantage of Robo4 KO mice and studied their
lymphocyte pools and lymphatic and blood vasculature in PP.
Special emphasis was put on the PP, because of the abundant
Robo4 expression on their lymphatics. The major lymphocyte
pools (B220, CD4, and CD8) did not differ statistically significantly
and they showed comparable anatomic localization in PP
(Fig. 3a–d). Numbers of CD4 and CD8 cells were lower in PLN of
KO mice than in their controls but such a difference was not
observed in MLN (Fig. S4a–d).
Despite the suggested role of Robo4 in angiogenesis and
lymphangiogenesis, the lymphatic and blood vasculature ana-
lyzed by using anti-LYVE1, anti-MAdCAM-1, and anti-CD31
antibodies was normal based on the area the vessels covered
and their microscopical appearance. Data regarding PP are shown
in Fig. 3e–h.
Robo4 contributes to lymphocyte entrance to PP
As Robo4 is abundantly present on blood endothelium, we first
checked its possible contribution to lymphocyte entrance into the
lymph nodes via HEV. We adoptively transferred congenic
CD45.1+ lymphocytes into Robo4 KO and WT animals and
analyzed them from PP, PLN, MLN, and peripheral blood 2 and
18 h after the i.v. injections. There was a slight decrease at the 2-h
time point in the homing of all CD45.1+ and CD45.1+ CD4+ cells
to the PP of Robo4 KO mice in comparison to their WT controls
(Fig. 4a). In contrast, no differences at the 18-h time point were
seen (Fig. 4b, the gating strategy is shown in Fig. S5a–d)
suggesting a statistically significant contribution for Robo4 in
lymphocyte homing via HEV to PP at early time points. A
concomitant increase in the number of transferred cells in
peripheral blood of KO mice was observed (Fig. 4c). We also
checked the homing of CD45.1+ lymphocytes to PLN and MLN
and observed a quantitatively minor, although statistically
significant decrease in the homing of different lymphocyte
subpopulations to these organs in Robo4 KO mice in comparison
to their WT controls (Fig. S5e–h). There were no significant
anatomical differences in the distribution of transferred cells
between the KO and WT mice in PP (Fig. 4d, e) or PLN and MLN
(Fig. S6a–d).
Robo4 is involved in B cell turnover in PP
To study the turnover of endogenous lymphocytes FITC was
injected into PPs. In this model, FITC will label the lymphocytes
and the kinetics of the turnover can simply be analyzed by
measuring the number of different FITC-positive lymphocyte
subsets retaining in PPs after 24 h. These studies showed that
more CD19+ and especially CD62hiCD44lo B cells were left in the
PPs of Robo4 KO than in those of WT mice suggesting a Robo4-
dependent mechanism regulating B cell turnover in PP (Fig. 5a, b).
There was no difference in the number of T cell subtypes
suggesting a clearly specific contribution of Robo4 towards the B
cell turnover. There was also a trend towards an impaired exit of
lymphocytes from popliteal lymph nodes to iliac lymph nodes
after lymphocyte transfer to footpads (Fig. S7a, b). We then
performed qPCR analyses of PP B cells to discover possible
changes in selected molecules known to be involved in
lymphocyte exit and maybe indirectly affected by lack of Robo4
on lymphatics or imprinting during the development as
Fig. 1 Robo4 is expressed on lymphatic and blood vessel endothelium. a, b Expression of Robo4 mRNA in peripheral lymph nodes (PLN, a) or
mesenteric lymph node (MLN, b) of wild-type C57BL/6J mice. mRNA expression was detected from lymphatic endothelial cells (CD45−, CD31+,
Podoplanin+, LEC) and blood endothelial cells (CD45−, CD31+, Podoplanin−, BEC). Data are from the Immunological genome project, mean
values above 120 (dashed red line) are regarded as positive with 95% confidence. c Robo4 protein expression is detected in WT BEC and LEC.
The cells were isolated and pooled from PLN and MLN. d Immunostaining of popliteal lymph node after subcutaneous (s.c.) administration of
Robo4-A647 antibody and ex vivo staining of CD31 and LYVE1 to detect the BEC and LEC cell populations. Scale bars 200, 50 µm zoom-ins, n=
3. e A schematic drawing of gut lymph nodes and lymphatics showing the Peyer's patches (PP), the efferent lymphatics leading from the lamina
propria and PP to the MLN, arrows point to the areas analyzed for Robo4 expression in f–h. Robo4 protein expression was analyzed with flow
cytometry from BEC, LEC, LYVE1+ LEC and LYVE1− LEC isolated from PP f, the gut-lining region g, and connecting lymphatics between the gut
and MLN h. i Robo4 expression in skin LEC. Black histograms, Robo4; gray histograms, isotype-specific control. Flow cytometry in c and f–i n= 3.
Data are presented as mean ± S.D. ***P < 0.001, **P < 0.01 (two-tailed Student’s t-test). M medulla, SS subcapsular sinus.
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hematopoietic stem cells express Robo4. PP B cells had
significantly less S1P receptor 1 signal most likely contributing
to the impaired turnover of B cells from the PP (Fig. S8a–c). We
next checked how well CD19+CD62LhiCD44lo B cells enter PP in
adoptive transfer assays. The results clearly showed that the
entrance of this B cell subpopulation was normal in Robo4 KO
mice (Fig. 5c). In the immunohistological analyses,
CD19+CD62LhiCD44lo B cells are mainly located in the mantle
zone of germinal centers in PP (Fig. 5d) and can be classified as
naïve based on their IgD positivity (Fig. 5e). When analyzing the
CD62LhiCD44lo population of total CD19+ B cells in the FITC-
injection experiments (Fig. 5a, b), no differences were found
between KO and WT animals (Fig. 5f) suggesting a slower turnover
for that population in the KO animals. We also employed thorough
endogenous B cell subtype analyses of PP and found that the
mean values of naïve and germinal center B cells in PP were
higher in the KO mice. This, however, showed only a trend in
statistical analyses (Fig. 5g–n). Similarly, the numbers of B cell
progenitors in bone marrows were comparable between Robo4
KO and their controls (Fig. S9a–e) as were the numbers of B cell
subpopulations in MLN expect for regulatory B cells, the number
of which were higher in KO mice (Fig. S9f–i).
Robo4 KO have slightly increased apoptosis in PP
As the KO mice retain CD19-positive B cells in PP in excess without
any difference in their entrance two possibilities remain; the PPs
have more apoptosis regulating the increasing cell amount over
time or they enlarge over time in Robo4 KO mice. We tested these
two possibilities. To study the rate of apoptosis we analyzed
Robo4 KO and WT PP lymphocytes by staining them for Annexin V
that binds to externally exposed phosphatidylserine on the cell
membrane. We analyzed the early apoptotic Annexin V+
population in total CD45+ hematopoietic cells, B220+ B cells,
and CD3+ T cells (Fig. 6a–c) and discovered that Robo4 KO mice
have a slight increase in the total cell number of CD45+ Annexin
V+ early apoptotic cells. The late stage of apoptosis was measured
with the TUNEL assay detecting cells with fragmented DNA from
Robo4 KO and WT PP-frozen sections (Fig. 6d, e). In these
stainings, the TUNEL assay revealed a comparable number and
localization of the apoptotic cells in the whole PP and the follicle
regions in Robo4 KO mice and their WT controls. Our data
suggests that Robo4 KO mice have a slightly activated rate of
apoptosis among B220+ B cells that may keep the size of PP under
control.
Imbalance in MLN homeostasis leads to increased tissue size
While Robo4 KO PP were not enlarged when their tissue weight
was normalized to the weight of the animal, MLN of Robo4 KO
mice had a greater mass when compared to their WT controls at
ages of 12 weeks or more (Fig. 7a, b). To study what would cause
the increased growth of MLN in these mice, we examined the size
of different B cell populations (Fig. 7c, d). The percentage of
CD19+CD62L−CD44+ population was slightly increased in Robo4
KO MLN (Fig. 7d). CD19+CD62LhiCD44lo B cells localized in the
mantle zone of B cell follicles similar to PP (Fig. 7e). However, an
increase in one B cell population does not explain the clear
increase in tissue weight. Therefore, we examined the total
percentage and number of CD19+ B cells, which was not altered in
Robo4 KO MLN (Fig. 7f). There was no increase in the total CD45+
hematopoietic cells in Robo4 KO MLN either (Fig. 7g). To study the
Fig. 2 Robo4 is expressed in human efferent lymphatics where it mediates binding of lymphocytes to the lymphatic sinus. a, b Low power
images of immunostaining of Robo4 and Clever-1 (a lymphatic endothelial marker) in human lymph nodes a. In the close-up images b the
arrowhead indicates Robo4+ Clever-1− blood vessel in the capsule, open arrows point to Robo4− Clever-1−/lo roof of SS and closed arrows
indicate the Robo4− Clever-1+ floor of SS; Robo4+ Clever-1+ lymphatics are only present in LS. c Immunostaining of Robo4 and Prox1 in the
human appendix. Arrows indicate Robo4+ Prox1+ lymphatic staining. Negative control stainings for Robo4 are shown in the boxed areas.
Representatives of three lymph nodes and three appendix samples from different individuals (scale bars 50 µm). d Adhesion of peripheral
blood lymphocytes to lymph node frozen sections (n= 12) analyzed by ex vivo adhesion assays of three different individuals. The sections
were treated with anti-Robo4 or an isotype control antibody and adhered lymphocytes were enumerated manually from the subcapsular and
lymphatic sinuses. Data is shown as the adhesion of lymphocytes to anti-Robo4-treated samples in relation to their isotype controls. The
control values were set as 100 by definition. Data are presented as mean ± S.D. ***P < 0.001 (two-tailed Student’s t-test). C capsule, SS
subcapsular sinus, LS lymphatic sinus.
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apoptotic rate, we stained MLN lymphocytes with Annexin V and
quantified the early apoptotic cells as well as the dead cells in
Robo4 KO MLN. Although the rate of early apoptotic cells was
comparable in Robo4 KO and WT MLN, a clear increase in the dead
cell population in CD45+ cells, B220+ B cells, and CD3+ T cells was
found (Fig. 7h, i). This was accompanied by increased collagen I
deposits (Fig. 7j).
DISCUSSION
The function of Robo4 as a regulator of angiogenesis, endothelial
cell migration, and blood vascular integrity has been demon-
strated.16,18,24 In contrast, very little is known regarding its
expression and function in the lymphatics. In this work, we found
Robo4 to be preferentially expressed on the efferent arm of the
lymphatic system. The finding was further confirmed by the
presence of Robo4 in the lymphatics of PP, which are by definition
efferent in their nature as PP do not have any afferent lymphatics.
However, when approaching the MLN the PP draining lymphatics
lose Robo4 expression—a finding that is compatible with the fact
that these same vessels become afferent for the MLN. The
expression pattern of Robo4 in these different arms of the
lymphatics opposes the expression of macrophage scavenger
receptor, which is discriminatively expressed on afferent lympha-
tics while being absent on the efferent ones.12
Although the diverse roles of Robo4 on blood endothelium
presented above have been demonstrated, its possible role in
leukocyte trafficking via HEV in organized lymphoid tissues has
not been addressed. About 80% of the lymphocytes are thought
to enter the lymph nodes via HEV while 20% enter via the afferent
lymphatics.25 To be able to address the role of Robo4 in the
trafficking dynamics of recirculating lymphocytes, we first studied
whether Robo4 on HEVs contributes to lymphocyte entrance into
the nodes. The results of these assays suggest that Robo4 does
Fig. 3 Robo4 KO mice have a normal number and distribution of lymphocytes and endothelial cells in PP. Frequency a and number b of B cells
(B220+), CD4+, and CD8+ T cells in the total lymphocyte pool in Robo4 KO and WT PP assessed by flow cytometry. Data are pooled from two
independent experiments with 8–9 WT and 9 Robo4 KO mice. c–h Immunostainings and quantifications of Robo4 KO and WT PP showing
distribution of lymphocyte subpopulations c, d, LYVE1+ lymphatics e, h, MAdCAM-1+ HEV detected with a secondary antibody after i.v.
injections of Meca367 antibody f, h or CD31+ blood vessels g, h. Images were quantified from 3 to 4 WT and 3 Robo4 KO mice from 1 to 2
individual PP per mouse and 1–3 sections per PP, scale bars 200 µm. Data are presented as mean ± S.D. Each dot represents an individual
mouse a, b or an analyzed sample c–h.
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have a minor contribution to the entrance of certain lymphocyte
subpopulations via the blood vessels into the PLN, MLN, and PP,
but the B cell homing via HEV to PP is at the same level both in
Robo4 KO and their WT controls. Therefore, it is unlikely that the
entry via HEV would contribute to the impaired turnover of the
B cells by any means.
Originally, we performed genome wide screening of endothe-
lial cells isolated from afferent and efferent lymphatics, because
we were interested in finding molecules discriminatively
expressed on the afferent and efferent arms of the lymphatic
vasculature.12 In addition, we were searching for potential
candidates that would be responsible either for the leukocyte
entry into the nodes or for selective lymphocyte access into the
efferent lymphatics while leaving the nodes. Therefore,
Robo4 seemed to be a good candidate in this respect. In
functional assays, we utilized Robo4 KO mice and injected FITC
locally into the PP. The results showed that a subset of
endogenous B cells accumulate and thus, may have difficulties
in leaving PP while CD4 and CD8 cells leave normally. We also
detected significantly lower levels of S1P receptor 1 in PP B cells
in Robo4 KO mice than in those of their WT controls. How can
Robo4 have an effect on this? One possibility is imprinting
during early developmental phases as Robo4 is expressed by
hematopoietic stem cells. Alternatively, lack of Robo4 in the
lymphatics may indirectly affect the exit machinery of the
lymphocytes.
Ex vivo-adhesion assays measuring lymphocyte binding to
HEV in frozen sections were originally presented by Stamper
and Woodruff.26 Since then, several modifications have been
employed including measurements of leukocyte and tumor cell
binding to different types of lymphatic vessels.23,27,28 Impor-
tantly this method has shown its usability for the molecular
identification of several interaction partners both on leukocytes
and vascular walls.29,30 Many of the molecules functionally
characterized this way have been later used as targets in drug
development.31–33 We also utilized this method to test, whether
anti-Robo4 antibody is able to inhibit lymphocyte binding to
lymphatics in human lymph nodes. The results of these assays
unambiguously demonstrated that lymphocyte–lymphatic
endothelial cell interaction in the LS but not in the SS is Robo4
dependent being in agreement with the expression pattern
of Robo4.
In conclusion, we have for the first time demonstrated the
discriminative expression of Robo4 in the efferent arm of the
lymphatic vasculature and its role in regulating the composition of
B cell populations in PP. This may happen at least partially by
adhesive interactions between B cells and endothelial cells within
LS. Robo4 differs from CXCR4, Clever-1, and sphingosine 1
phosphate, which contribute to lymphocyte egress from PP but
are also involved in lymphocyte trafficking in the afferent arm of
the lymphatics.34–36 This finding is expected to facilitate future
studies regarding the possibilities to target Robo4 and thus,
manipulate the immune response.
MATERIALS AND METHODS
Mice
C57BL/6 mice were purchased from Jackson Laboratory and
Janvier labs. Robo4 KO mice, 129S6(B6)-Robo4tm1Lex/Mmucd
(stock number 032543-UCD), and their wild-type controls from
Fig. 4 Vascular Robo4 regulates short-term lymphocyte migration to PP a, b Relative number of adoptively transferred CD45.1+ total
lymphocytes, CD19+ CD45.1+ B cells, CD4+ CD45.1+, and CD8+ CD45.1+ T cells recovered in PP with flow cytometry 2 h a or 18 h b after
intravenous injections of donor cells into Robo4 KO and WT recipients. c Relative amount of adoptively transferred CD45.1+ lymphocytes
recovered from peripheral blood with flow cytometry 2 h (top) or 18 h (bottom) after intravenous injections of donor cells into Robo4 KO and
WT recipients. In a–c data are pooled from three independent 2-h and two independent 18-h adoptive transfer assays with 15–17 Robo4 KO
and 15–18 WT (2-h) or 12–13 Robo4 KO and 9–11 WT mice (18-h). The mean value of WT mice is defined as 1.0. d, e The distribution of
adoptively transferred CD45.1+ cells was analyzed from PP-frozen sections and the percentage (%) of CD45.1+ cells was quantified from
CD19+ B cell follicles d or CD19− inter-follicular regions e at 2 h (top) or 18 h (bottom) after intravenous injections based on the signal area
covered by CD45.1+ cells/total area analyzed. Image quantification was performed from 1 to 2 independent 2 and 18-h experiments analyzing
3–9 Robo4 KO and WT mice. Sections were analyzed from a total of 8–12 d or 4–10 e PP. Representative images are shown from the 18-h
adoptive transfer experiment (scale bars= 100 µm). Data are presented as mean ± S.D. *P < 0.05, **P < 0.01, ***P < 0.001 (Mann–Whitney
U-test). Each dot represents an individual mouse a–c or an analyzed sample d, e. F follicle, I inter-follicular region.
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the same genetic background were purchased from Lexicon
genetics Inc. Mice were bred as separate Robo4 KO and WT lines.
Congenic CD45.1+ B6.SJL-Ptprca Pepcb/BoyJ mice were pur-
chased from Jackson Laboratory (stock number 002014). Age
and sex-matched controls were used for the study. Robo4 KO
mice have originally been subjected to a broad phenotypic
screen aiming at identifying defects in metabolism, function of
the cardiovascular, neurological, or immunological systems, as
well as involvement in oncogenesis, but no notable phenotype
alterations were found.37 All animal experiments were approved
by the Ethical Committee for Animal Experimentation in Finland
and Germany. Experiments were performed according to the
rules and regulations of The Finnish Act on Animal Experimenta-
tion (497/2013) in compliance with the 3R-principle with the
appropriate animal licenses (5587/04.10.07/2014, 5762/04.10.07/
2017 and 84-02.04.2014.A330).
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Human material
Human lymph nodes and appendix samples were obtained from
surplus tissues from surgical operations. Tissues were carefully
examined macroscopically and microscopically before using
tissues for experiments. Only tissues that were observed as
normal were used for further experimentation. Mononuclear cells
were isolated from healthy volunteers with the permission of the
Ethical Committee of the Turku University Hospital.
Antibodies
The antibodies used in this work are listed in Supplementary
Table 1.
Flow cytometry
When analyzing lymphocytes, single-cell suspensions were prepared
by homogenizing PLN, MLN, and PP with custom-made metal cell
strainers or nylon filters followed by additional filtering. LEC and
Fig. 6 Robo4 KO mice have slightly increased apoptosis in PP. a–c Early apoptotic cells in Robo4 KO and WT PP. Frequency (%) and total cell
numbers in relation to mg of tissue of early apoptotic Annexin+ CD45+ cells a, Annexin+ B220+ B cells b, and Annexin+ CD3+ T cells
c analyzed from Robo4 KO and WT PP. Apoptotic cells were quantified from two independent experiments using 8–9 WT and 9–10 KO mice.
d Representative images from Robo4 KO and WT PP showing end-phase apoptotic cells detected with TUNEL assay, B220+ B cells and LYVE1+
lymphatics (scale bars 200 µm in main images, 100 µm in zoom-ins). e Quantification of the percentage (%) of TUNEL+ area in Robo4 KO and
WT PP analyzed from the whole PP area (top) of follicle area (bottom). Quantification of TUNEL+ signal was performed from six WT and five KO
PP isolated from three WT and three KO mice. Data are presented as mean ± S.D. *P < 0.05 (Mann–Whitney U-test). F follicle.
Fig. 5 Robo4 KO mice retain especially CD19+CD62LhiCD44lo B cells in their PP. a Representative plots showing frequencies of
FITC+CD62LhiCD44locells among CD19+ cells in FITC-injected PP 24 h post injections. b Frequency of FITC+ CD19+CD62LhiCD44lo B cells (left),
CD4+CD62LhiCD44lo T cells (middle) and CD8+CD62LhiCD44lo T cells (right) recovered by flow cytometry from FITC-injected Robo4 KO and WT
PP 24 h after FITC injections. Combined data are pooled from three individual experiments performed with six WT and six KO mice per group.
c Relative number of adoptively transferred naïve CD19+CD62LhiCD44lo CD45.1+ B cells recovered from Robo4 KO and WT PP with flow
cytometry 18 h after intravenous injections of CD45.1+ donor cells into Robo4 KO and WT recipients. Data are from seven WT and five KO
mice. d Localization of CD19+CD62LhiCD44lo B cells. Arrows point to clusters of these cells (scale bars 200 µm in main images, 20 µm in zoom-
ins), n= 3 WT and 3 KO mice. e Gating of the CD19+CD62hiCD44lo population of B cells for the analysis of IgD positivity (naïve B cells).
f Frequency (%) of the CD62LhiCD44lo population of total CD19+ B cells in the experiments described in a and b. g–n Analysis of endogenous
B cell populations in Robo4 KO and WT PP. Gating strategy and quantification of naïve B cells (B220+ IgD+; g, h), activated B cells (B220+
CD19+ CD40+ MHCII+, i, j), germinal center B cells (B220+ IgDlo CD95+ GL7+, k, l) and regulatory B cells (CD19+ CD1d+ CD5+, m, n). The
percentage (%) of B cell subpopulations was normalized to B220+ B cells (left graph) and the number of B cell subpopulations is reported in
relation to mg of tissue (right graph). Endogenous B cells were quantified from two independent experiments using 9 WT and 9 KO mice. Each
dot represents an individual PP b, f or an individual mouse (c, h, j, l, n). Data are presented as mean ± SD. ***P < 0.001 (Mann–Whitney U-test).
T T cell area, GC germinal center.
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BEC were isolated as described previously.12 Cells were blocked
using the anti-CD16/CD32 Mouse BD Fc Block™ (BD 553141) or 5%
rat serum before staining the cells with appropriate combinations of
fluorescently labeled monoclonal antibodies. Cells were analyzed
with an LSR II or LSR Fortessa cytometer (Becton Dickinson) that
were appropriately calibrated for each antibody cocktail using
UltraComp eBeads™ Compensation beads (Invitrogen™, 01-2222-41).
Data was analyzed using FlowJo software (FlowJo LLC).
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Subcutaneous administration of anti-Robo4 antibody
In-house produced monoclonal anti-Robo4 antibody (see Supple-
mentary methods) was conjugated using the Alexa Fluor™ 647
Protein Labeling Kit (Invitrogen™, A20173). Before injections, the
antibody was filtered using a 10-kDa cut-off centrifugal filter unit
(Millipore, MRCPRT010) to remove any free fluorochromes. A
blocking mixture targeted to block the Fc receptors present on
macrophages was a combination of 50 µg anti-CD16/CD32 (clone
2.4G2, Bio X Cell BE0307) and 50 µg mouse immunoglobulins
(Rockland 010-0102-0005). 20 µl of the blocking mixture was
administered to the footpads of C57BL/6 mice, which were under
light isoflurane anesthesia. The blocking antibodies and immu-
noglobulins were let to drain to the popliteal lymph node for
15min. 5 µg of anti-Robo4 antibody (clone FuRFM7) was injected
simultaneously with 50 µg of anti-CD16/CD32 and 50 µg of mouse
Ig s.c. to the calves of the mice and antibodies were let to drain to
the popliteal lymph node for an additional 15min after which the
mice were sacrificed, the lymph nodes excised, embedded in
optimal cutting temperature (OCT) medium in a predetermined
orientation in order to produce transverse sections of the lymph
node and snap-frozen using dry ice. The samples were stored
at −70 °C and 6 µm sections were cut for imaging. The lymph
node tissue sections were subjected to immunofluorescence
staining of vascular and lymphatic markers CD31-A488 (BioLe-
gend®, 102514) and LYVE1 (ReliaTech GmbH, 103-PA50) followed
by a conjugated secondary antibody, Goat anti-rabbit Alexa Fluor®
546 (Invitrogen™, A11035). Samples were imaged using a LSM780
confocal microscope (Carl Zeiss) as described below.
Immunohistochemistry
Processing tissues for microscopy. Harvesting and treating PP for
imaging was performed as previously described.34 Upon harvest-
ing PP no external pressure was applied to the tissue in order to
preserve the lymphatic contents. PP were harvested attached to a
ring of the intestine that was flushed with PBS to empty the
intestinal contents. The PP were fixed in 4% PFA for 2–4 h, washed
twice with PBS and incubated overnight in 30% sucrose. On the
following day, PP were embedded in OCT medium in a
predetermined position in order to produce transverse sections
of the PP. Inguinal lymph nodes and the MLN were harvested and
excess fat tissue was removed. LN were fixed in 4% PFA for 2–4 h,
incubated in 30% sucrose overnight and embedded in OCT
medium on the following day. Blocks were snap-frozen using dry
ice, stored at −70 °C and used for cutting 6 µm sections. Tissue
sections were subjected for immunofluorescence staining by
incubating them with predetermined antibody dilutions for 30–60
min each at room temperature. Stained sections were mounted
using ProLong™ Gold Antifade Mountant with DAPI (Invitrogen™,
P36931) or without DAPI (Invitrogen™, P10144). In some cases, PP
and MLN were embedded in OCT medium without PFA fixation
and the sections were subsequently fixed with ice-cold acetone
before staining.
Human lymph nodes and appendixes were collected from three
different donors and they were embedded in OCT medium, snap-
frozen with dry ice, stored at −70 °C and used for cutting 5 µm
sections fixed with acetone. Non-specific-binding sites were
blocked with 5% human AB serum for 10min at room
temperature. Sections were stained with predetermined antibody
dilutions for 30 min each at room temperature and mounted using
ProLong™ Gold Antifade Mountant.
Imaging. The immunofluorescently stained sections were
imaged using a LSM780 or LSM880 confocal microscope (Carl
Zeiss) with a Plan-Apochromat ×20/0.8 objective. Zen 2010 or Zen
2.3 SP1 FP2 software (Carl Zeiss) was used for acquiring images.
The same slice thickness for each channel was determined by
adjusting the pinhole resulting in a slice thickness varying from 2.3
to 8.8 µm. In some cases, images were acquired using an Olympus
BX60 fluorescence microscope (Tokyo, Japan) equipped with a
UPlanFI ×20/0.50 or an UPlanFI ×40/0.75 objective or a Nikon
Eclipse TI-E fluorescence microscope and a Plan Apo lamda ×20/
0.80 objective.
Image analyses were performed using ImageJ software (version
1.52i). Linear brightness adjustments were applied equally to
Robo4 KO and WT images, as well as human tissue images and
their controls. Image quantification was performed by threshold-
ing the appropriate signal and calculating area fractions for the
tissues. Thresholding was applied equally to all analyzed images.
When analyzing collagen I, background subtraction was per-
formed before thresholding. Adoptive transfer image quantifica-
tions were done by thresholding CD45.1+ signal and calculating
area fractions of determined regions of interest, such as follicular
and interfollicular regions (PP) or CD19+ B cell regions, as well as
CD4+ T cell regions (MLN, PLN). MLN samples were analyzed from
a representative area of 1.61–1.62 mm2. Collagen I+ signal was
thresholded and the total area and percentage of collagen I+
signal were analyzed from two representative 0.24 mm2 areas/
sample.
Apoptosis assay
Annexin V. To analyze the apoptotic rate and dead cells in Robo4
KO and WT tissues, we stained single-cell suspensions extracted
from PP and MLN with Fixable Viability Dye eFluor 506
(eBioscience 65-0866-14) diluted in PBS for 30min on ice. After
washes, the cells were blocked with the anti-CD16/CD32 Mouse
BD Fc Block™ and incubated with fluorescently conjugated
antibodies for 30 min on ice as described above. After staining
with antibodies, cells were washed with PBS and incubated with
Annexin V-PE (BD 556422) diluted 1:200 in 1x Annexin-staining
buffer comprised of 0.01 M HEPES (pH 7.4), 0.14 M NaCl, and
Fig. 7 Differences in cell death and collagen homeostasis lead to increased MLN size in Robo4 KO mice. a, b Weight of single PP a and MLN
b in relation to the total weight of the mouse analyzed from Robo4 KO and WTmice under the age of 12 weeks or 12 weeks and older. Tissues
were weighed from 27 WT and 27 KO (<12 weeks), 20–26 WT and 17–23 KO (>12 weeks) mice. c, d Gating and analysis of CD19+ B cell
subpopulations from >12 weeks old mice. c FACS plots of CD19+ subpopulations from Robo4 KO and WT MLN analyzed from >12-week-old
mice. d Frequency (%) and total cell numbers in relation to mg of tissue for CD19+CD62LhiCD44lo (left), CD19+CD62LhiCD44+ (middle) and
CD19+CD62L−CD44+ (right) B cells recovered by flow cytometry of MLN of Robo4 KO and WTmice, age > 12 weeks. Data are representative of
two independent experiments performed with a total of 11–12 WT and KO mice. e Localization of CD19+CD62LhiCD44lo B cells in MLN of
Robo4 KO and WT detected by immunostaining, age > 12 weeks. Arrows point to these cells (scale bars 100 µm in main images, 20 µm in
zoom-ins). f, g Frequency (%) and total cell numbers in relation to mg of tissue of CD19+ B cells f and CD45+ cells g analyzed by flow
cytometry from Robo4 KO and WT MLN, age > 12 weeks. Data are pooled from two independent experiments with 11 WT and 12 KO mice.
h, i Frequency (%) and total cell numbers in relation to mg of tissue of early apoptotic Annexin+ CD45+ cells, Annexin+ B220+ B cells, and
Annexin+ CD3+ T cells h, as well as dead CD45+, dead B220+, and dead CD3+ cells i analyzed from Robo4 KO and WT MLN, age >12 weeks.
5–6 WT and 6 KO mice were analyzed. j Quantification of collagen I from fluorescence images of Robo4 KO and WT MLNs, age > 12 weeks.
Examples of the collagen I expression (left), combined results of the expression (right). Images were acquired from six WT and six KO mice and
collagen I was quantified from two regions of 0.24 mm2 for each MLN, scale bars 100 µm. Each dot represents an individual mouse (a, b, d, f–i)
or an analyzed sample j. Data are presented as mean ± S.D. *P < 0.05, **P < 0.01, ***P < 0.001 (Mann-Whitney U-test).
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2.5 mM CaCl2. The samples were incubated for 15 min at room
temperature, additional Annexin-staining buffer was added to the
cells and samples were analyzed immediately using an LSR
Fortessa cytometer (Becton Dickinson).
TUNEL. Robo4 KO and WT PP were harvested, fixed in 4% PFA for
4 h, washed with PBS twice and incubated overnight in 30%
sucrose. PP were mounted the following day in OCT medium as
described above. Frozen sections of 5–6 µm were cut and
apoptotic cells were detected from Robo4 KO and WT PP using
the commercially available Click-iT™ Plus TUNEL Assay (Invitro-
gen™, C10618) fluorescently detecting the 3′-OH ends of
fragmented DNA. The assay was performed according to the
manufacturer’s instructions. The sections were subsequently
subjected to antibody staining detecting B cells and lymphatics.
TUNEL staining was quantified using ImageJ by thresholding the
TUNEL+ signal and calculating area fractions of the signal in
relation to the whole PP or follicular areas.
Intravenous staining of PP HEV
Mucosal HEV were quantified using intravenous labeling of
endothelial cells with anti-MAdCAM-1 antibody. For quantifying
MAdCAM-1+ HEVs in Robo4 KO and WT PP tissue sections, 10 µg
of anti-MAdCAM-1 antibody (clone Meca367, a gift from Prof.
E. Butcher) was administered to Robo4 KO and WT mice
intravenously to label the lumens of HEVs. Mice were sacrificed
10min later and the PP were harvested. Frozen sections were
stained with the secondary antibody Goat anti-rat IgG Alexa Fluor
546 (Invitrogen™, A11081) detecting Meca367. The sections were
simultaneously stained for CD31 and IgD.
Adoptive transfer assays
Lymphocytes were isolated from skin-draining, mesenteric and
cervical lymph nodes of wild-type, congenic CD45.1+ donor mice.
Tissues were homogenized using metal custom-made cell
strainers to produce a single-cell suspension. 12 × 106 CD45.1+
lymphocytes were intravenously transferred into CD45.2+ Robo4
KO and WT mice. PLN (inguinal, axillary, brachial), MLN, PP, and
peripheral blood of the recipient mice were analyzed 2 and 18 h
after the intravenous transfer.
In another set of experiments, lymphocytes were isolated from
the spleens, skin-draining lymph nodes, and cervical lymph nodes
of Robo4 WT mice. Donor cells were labeled with 0.5 µM
CellTrace™ CFSE (Invitrogen™, C34554) and 10 × 106 cells were
subcutaneously injected into the hind leg footpads of Robo4 KO
and WT recipient mice. Popliteal and iliac lymph nodes were
analyzed with flow cytometry 12 h after the adoptive transfer.
FITC injection into PP
FITC injection into PP was done as previously described.38 Briefly,
mice were anesthetized and the small intestine was exposed after
small incisions into the skin and peritoneum. Fluorescein
isothiocyanate (FITC, Sigma-Aldrich) solution diluted in PBS at
the concentration of 1 mg/ml was injected into 4–5 PP per mouse.
For injections, fine glass capillaries connected to a microinjector
(Harvard Apparatus) were used. After the injections, the small
intestine was placed back into the abdominal cavity and the
wounds were closed with sutures and metal clips. The mice were
analyzed 1 day after the FITC injections with flow cytometry.
Ex vivo-adhesion assays
In principle, the adhesion assays were performed as described
earlier.23 Briefly, human lymphocytes from healthy volunteers
were isolated from peripheral blood using Ficoll-Paque™
(GE Healthcare) density gradient purification. Isolated lymphocytes
were incubated on freshly cut frozen sections of human peripheral
lymph nodes pre-treated for 30 min with rabbit anti-human Robo4
antibody (ab10547, Abcam) or normal rabbit serum as a negative
control. Lymphocytes were allowed to bind to the sinuses for 5
min in rotatory conditions, in steady-state conditions for 15 min
followed by 5min in rotatory conditions and thereafter, 15 min
without rotation at +7 °C. The non-bound cells were gently
decanted off from the sections and adherent cells were fixed with
1% glutaraldehyde. The number of lymphocytes bound to the SS
and LS was counted under dark-field microscopy. To be able to
standardize day-to-day variations between the experiments, the
binding of lymphocytes to the control sections was set to 100% by
definition.
Statistical analyses
Sample size for experiments was determined with pilot assays. All
numerical data are presented as mean ± S.D. Comparisons
between the genotypes or differently treated groups were
analyzed using the Mann–Whitney U-test or the two-tailed
Student’s t-test. All statistical analyses were performed with
GraphPad Prism v7 software (GraphPad software Inc.). Outliers in
data were determined using the Grubb’s test available from
GraphPad Prism and removed from the analyses. P-values under
0.05 were considered as statistically significant.
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